Ain Shams University Hospitals
Cairo, 11511, Egypt
NCT Number: NCT07780409
This prospective single-arm interventional study evaluated the efficacy and safety of flexible ureteroscopy for the treatment of large renal stones measuring 2 cm or more in pediatric patients. All enrolled participants underwent flexible ureteroscopic stone disintegration using a single-use flexible ureteroscope and Holmium laser lithotripsy. The study was designed to assess whether this minimally invasive approach could provide effective stone clearance with acceptable perioperative safety in children with large renal stones.
Looking for future studies?
Notify Me0 year–13 year
All sexes
Interventional
Not applicable
Cairo, 11511, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Flexible ureteroscopy was performed using a 7.5-Fr single-use flexible ureteroscope. Renal stones were fragmented with a Holmium:YAG laser. A ureteral access sheath was used when feasible, and a double-J ureteral stent was placed at the end of the procedure.
Time frame: 1 month after the procedure
Stone-free status was assessed by computed tomography of the urinary tract (CTUT) after flexible ureteroscopic stone disintegration. The proportion of participants meeting the study-defined criteria for stone-free status was recorded.
Time frame: Intraoperatively
Duration of the flexible ureteroscopic procedure was recorded for each participant.
Cairo University
Other
Flexible Ureteroscopic Stone Disintegration in Pediatric Age Group for Large Renal Stones (≥2 cm)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05088213
Calculi, Female Urogenital Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT05701098
Calculi, Female Urogenital Diseases
San Diego, California, United States
View Trial DetailsNCT07286071
Calculi, Female Urogenital Diseases
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT07345234
Calculi, Female Urogenital Diseases
Cairo, Cairo Governorate, Egypt
View Trial Details